SDZ ENA 713 blocker of acetylcholine breakdown: Began recruiting for a worldwide Phase III trial in 2,400 patients with mild to moderate, probable Alzheimer's d

Sandoz Pharma Ltd., Basel
Product: SDZ ENA

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.